Vanrafia Interactions
There are 98 drugs known to interact with Vanrafia (atrasentan), along with 2 disease interactions. Of the total drug interactions, 57 are major, and 41 are moderate.
- View all 98 medications that may interact with Vanrafia
- View Vanrafia disease interactions (2)
Most frequently checked interactions
View interaction reports for Vanrafia (atrasentan) and the medicines listed below.
- allopurinol
- amlodipine
- azelastine nasal
- benazepril
- colchicine
- famotidine
- Farxiga (dapagliflozin)
- Filspari (sparsentan)
- Gaviscon Extra Strength (aluminum hydroxide / magnesium carbonate)
- gemfibrozil
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Juluca (dolutegravir / rilpivirine)
- labetalol
- lisinopril
- loratadine
- Lovaza (omega-3 polyunsaturated fatty acids)
- methocarbamol
- olmesartan
- omeprazole
- prednisone
- Prezista (darunavir)
- Qvar RediHaler (beclomethasone)
- spironolactone
- Tamiflu (oseltamivir)
- Tessalon Perles (benzonatate)
- trazodone
- Uloric (febuxostat)
- Ultracet (acetaminophen / tramadol)
- valsartan
- Vitamin D3 (cholecalciferol)
Vanrafia disease interactions
There are 2 disease interactions with Vanrafia (atrasentan) which include:
Report options
QR code containing a link to this page
More about Vanrafia (atrasentan)
- Vanrafia consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous genitourinary tract agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.